论文部分内容阅读
目的探讨血糖及C-反应蛋白(CRP)在急性脑血管疾病(ACVD)发病早期血液中含量变化对疾病病情程度及预后判断上的价值.方法对160例ACVD患者进行研究,所有患者均于发病24小时内空腹采血测血糖和CRP,根据血糖结果将病人分为高血糖组和正常血糖组,对高血糖组的病情预后与正常血糖组进行对比分析;按临床神经功能缺损程度评分(NDS),将入院时和入院4周的结果判断转归,将基本痊愈、显著进步、进步患者归为好转组,无变化.恶化、死亡归为无好转组,并对两组的CRP异常宰进行比较。结果(1)高血糖组较正常血糖组患者病情程度重,预后差.(2)好转组的CRP异常率明显低于无好转组;统计学上差异有显著性.结论急性脑血管病的发病早期血糖及CRP水平对判断病情,估计预后有一定的临床价值.
Objective To investigate the blood levels of blood glucose and C-reactive protein (CRP) in the early stage of acute cerebrovascular disease (ACVD) and evaluate their clinical significance and prognosis.Methods 160 patients with ACVD were studied, Fasting blood glucose was measured within 24 hours and CRP, the patients were divided into hyperglycemia group and normal blood glucose group according to the results of blood glucose, and the prognosis of hyperglycemia group was compared with that of normal blood glucose group. According to the score of clinical neurological deficit (NDS) , The results of admission and admission 4 weeks to judge the prognosis, will be basically recovered, significant progress, progressive patients are classified as improvement group, no change.Degradation, death as no improvement group, and the two groups of CRP abnormalities were compared . Results (1) The patients with hyperglycemia were more serious and the prognosis was worse than that of patients with normal glucose (2) The abnormal rate of CRP in the remission group was significantly lower than that in the non-remission group, and the difference was statistically significant.Conclusion The incidence of acute cerebrovascular disease Early blood glucose and CRP levels to determine the condition, the prognosis of a certain clinical value.